相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of MHC I Molecules in Glioblastoma Cells and the Sensitizing of NK Cells
Timo Burster et al.
PHARMACEUTICALS (2021)
Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells
Timo Burster et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Dual metabolic reprogramming by ONC201/TIC10 and 2-Deoxyglucose induces energy depletion and synergistic anti-cancer activity in glioblastoma
Maximilian Pruss et al.
BRITISH JOURNAL OF CANCER (2020)
Considering the Experimental Use of Temozolomide in Glioblastoma Research
Verena J. Herbener et al.
BIOMEDICINES (2020)
Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
Hera Saqub et al.
SCIENTIFIC REPORTS (2020)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
Hannah Strobel et al.
BIOMEDICINES (2019)
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
Lukas Bunse et al.
NATURE MEDICINE (2018)
Viability of glioblastoma stem cells is effectively reduced by diisothiocyanate-derived mercapturic acids
Kamila Cwiklowska et al.
ONCOLOGY LETTERS (2018)
A paired comparison between glioblastoma stem cells and differentiated cells
Matthias Schneider et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Synthesis and biological activity of diisothiocyanate-derived mercapturic acids
Renata Grzywa et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
The challenges associated with molecular targeted therapies for glioblastoma
Toni Rose Jue et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
Zhenghu Chen et al.
SCIENTIFIC REPORTS (2016)
Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737-Mediated Cell Death in Malignant Human Glioma Cell Lines
Esther P. Jane et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy
Stephanie Stroebele et al.
PLOS ONE (2015)
Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research
Shivendra V. Singh et al.
CARCINOGENESIS (2012)
Glucosinolates and isothiocyanates in health and disease
Albena T. Dinkova-Kostova et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate
Dunyaporn Trachootham et al.
CANCER CELL (2006)
分享论文
